Bacteremia [clinicaltrials_resource:40bc07e485ce333640da9bfdc59f7f33]
Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections [clinicaltrials:NCT00027248]Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria [clinicaltrials:NCT00037050]Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections [clinicaltrials:NCT00057369]Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [clinicaltrials:NCT00093067]clinicaltrials:NCT00108433clinicaltrials:NCT00122642Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections [clinicaltrials:NCT00130221]The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study [clinicaltrials:NCT00164099]Pharmacodynamic Parameters of Two Different Doses of Cefepime [clinicaltrials:NCT00177736]Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [clinicaltrials:NCT00235690]Prevention of Bacteremia Induced by Debridement of Pressure Ulcer [clinicaltrials:NCT00269100]clinicaltrials:NCT00319826clinicaltrials:NCT00398411Infections Caused by ESbL-Producing Enterobacteriaceae in Italy [clinicaltrials:NCT00404625]Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis [clinicaltrials:NCT00406198]Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase [clinicaltrials:NCT00414193]Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin [clinicaltrials:NCT00414362]clinicaltrials:NCT00417235clinicaltrials:NCT00428051Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion [clinicaltrials:NCT00435305]Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing [clinicaltrials:NCT00454285]Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [clinicaltrials:NCT00505258]clinicaltrials:NCT00509847Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride [clinicaltrials:NCT00515151]clinicaltrials:NCT00518687Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia [clinicaltrials:NCT00548002]Prophylactic Antimicrobial Catheter Lock [clinicaltrials:NCT00571259]Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen [clinicaltrials:NCT00609375]UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling [clinicaltrials:NCT00639197]Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source [clinicaltrials:NCT00692848]Procalcitonin Level and Kinetics in Children With Bacterial Infections [clinicaltrials:NCT00714402]clinicaltrials:NCT00735813MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial [clinicaltrials:NCT00814151]Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation [clinicaltrials:NCT00835783]Central Venous Catheter Lock Solution [clinicaltrials:NCT00862966]Lebanese Interhospital Pneumococcal Surveillance Program [clinicaltrials:NCT00901602]Comparison of Infection Rates Among Patients Using Two Catheter Access Devices [clinicaltrials:NCT00965198]Effectiveness of Routine Sterile Gloving in Blood Culture [clinicaltrials:NCT00973063]Increasing the Yield of Blood Cultures in Neonates [clinicaltrials:NCT01023555]The Impact of Material on Microbiota in Association With Tongue and Lip Piercing [clinicaltrials:NCT01039259]
condition [clinicaltrials_vocabulary:condition]
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [clinicaltrials:NCT00002192]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections [clinicaltrials:NCT00027248]Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria [clinicaltrials:NCT00037050]Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections [clinicaltrials:NCT00057369]clinicaltrials:NCT00062647Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever [clinicaltrials:NCT00063089]Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [clinicaltrials:NCT00093067]clinicaltrials:NCT00108433Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants [clinicaltrials:NCT00113191]clinicaltrials:NCT00122642Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections [clinicaltrials:NCT00130221]Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation [clinicaltrials:NCT00138112]The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study [clinicaltrials:NCT00164099]Pharmacodynamic Parameters of Two Different Doses of Cefepime [clinicaltrials:NCT00177736]Gram Negative Bacteremia, Risk Factors for Failure of Therapy [clinicaltrials:NCT00177957]Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) [clinicaltrials:NCT00198302]Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [clinicaltrials:NCT00235690]Prevention of Bacteremia Induced by Debridement of Pressure Ulcer [clinicaltrials:NCT00269100]Chart Review of Outcome of Treatment for S. Aureus Bacteremia [clinicaltrials:NCT00304902]clinicaltrials:NCT00319826Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study [clinicaltrials:NCT00326313]clinicaltrials:NCT00398411Infections Caused by ESbL-Producing Enterobacteriaceae in Italy [clinicaltrials:NCT00404625]Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis [clinicaltrials:NCT00406198]Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase [clinicaltrials:NCT00414193]Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin [clinicaltrials:NCT00414362]clinicaltrials:NCT00417235clinicaltrials:NCT00428051Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion [clinicaltrials:NCT00435305]The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections [clinicaltrials:NCT00448942]Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing [clinicaltrials:NCT00454285]Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections [clinicaltrials:NCT00502476]Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [clinicaltrials:NCT00505258]clinicaltrials:NCT00509847
condition browse [clinicaltrials_vocabulary:condition-browse]
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. [clinicaltrials:NCT00002192]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections [clinicaltrials:NCT00027248]Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria [clinicaltrials:NCT00037050]Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections [clinicaltrials:NCT00057369]clinicaltrials:NCT00062647Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever [clinicaltrials:NCT00063089]Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus [clinicaltrials:NCT00093067]clinicaltrials:NCT00108433Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants [clinicaltrials:NCT00113191]clinicaltrials:NCT00122642Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections [clinicaltrials:NCT00130221]Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation [clinicaltrials:NCT00138112]The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study [clinicaltrials:NCT00164099]Pharmacodynamic Parameters of Two Different Doses of Cefepime [clinicaltrials:NCT00177736]Gram Negative Bacteremia, Risk Factors for Failure of Therapy [clinicaltrials:NCT00177957]Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) [clinicaltrials:NCT00198302]Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [clinicaltrials:NCT00235690]Prevention of Bacteremia Induced by Debridement of Pressure Ulcer [clinicaltrials:NCT00269100]Chart Review of Outcome of Treatment for S. Aureus Bacteremia [clinicaltrials:NCT00304902]clinicaltrials:NCT00319826Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study [clinicaltrials:NCT00326313]clinicaltrials:NCT00398411Infections Caused by ESbL-Producing Enterobacteriaceae in Italy [clinicaltrials:NCT00404625]Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis [clinicaltrials:NCT00406198]Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase [clinicaltrials:NCT00414193]Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin [clinicaltrials:NCT00414362]clinicaltrials:NCT00417235clinicaltrials:NCT00428051Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion [clinicaltrials:NCT00435305]The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections [clinicaltrials:NCT00448942]Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing [clinicaltrials:NCT00454285]Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections [clinicaltrials:NCT00502476]Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [clinicaltrials:NCT00505258]clinicaltrials:NCT00509847
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Bacteremia [clinicaltrials_resource:40bc07e485ce333640da9bfdc59f7f33]
Bio2RDF identifier
40bc07e485ce333640da9bfdc59f7f33
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:40bc07e485ce333640da9bfdc59f7f33
identifier
clinicaltrials_resource:40bc07e485ce333640da9bfdc59f7f33
title
Bacteremia
@en
type
label
Bacteremia [clinicaltrials_resource:40bc07e485ce333640da9bfdc59f7f33]
@en
Bacteremia